Skip to main content

Table 2 The mean Foxp3/CD3 and Foxp3/CD4 ratios according to the patient group

From: Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer

 

Cancer

Node positive

Node negative

Control

Foxp3:CD3*

0.24

0.26

0.17

0.14

Foxp3:CD4*

0.29

0.31

0.19

0.14

  1. Ratio of Foxp3+ cells to that of other T cell markers.
  2. * p < 0.001 for cancer patients compared to controls, and node-positive patients compared to node-negative patients.